Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
AYTU — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.6

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.51

EPS Last/This Y

1.03

EPS This/Next Y

1.06

Price

2.33

Target Price

9.5

Analyst Recom

1

Performance Q

-4.45

Upside

-6,892.4%

Beta

0.27

Ticker: AYTU



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-14AYTU2.2N/AN/A0
2026-07-15AYTU2.23N/AN/A0
2026-07-16AYTU2.16N/AN/A0
2026-07-17AYTU2.15N/AN/A0
2026-07-20AYTU2.18N/AN/A0
2026-07-21AYTU2.19N/AN/A0
2026-07-22AYTU2.17N/AN/A0
2026-07-23AYTU2.17N/AN/A0
2026-07-24AYTU2.16N/AN/A0
2026-07-27AYTU2.07N/AN/A0
2026-07-28AYTU2.14N/AN/A0
2026-07-29AYTU2.08N/AN/A0
2026-07-30AYTU2.13N/AN/A0
2026-07-31AYTU2.24N/AN/A0
2026-08-03AYTU2.25N/AN/A0
2026-08-04AYTU2.22N/AN/A0
2026-08-05AYTU2.29N/AN/A0
2026-08-06AYTU2.27N/AN/A0
2026-08-07AYTU2.33N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-14AYTU2.21-100.0- -1.14
2026-07-15AYTU2.24-100.0- -1.14
2026-07-16AYTU2.19-100.0- -1.14
2026-07-17AYTU2.15-100.0- -1.14
2026-07-20AYTU2.18-100.0- -1.14
2026-07-21AYTU2.17-100.0- -1.14
2026-07-22AYTU2.16-100.0- -1.14
2026-07-23AYTU2.16-100.0- -1.14
2026-07-24AYTU2.16-100.0- -1.14
2026-07-27AYTU2.05-100.0- -1.14
2026-07-28AYTU2.14-100.0- -1.14
2026-07-29AYTU2.09-100.0- -1.14
2026-07-30AYTU2.16-100.0- -1.14
2026-07-31AYTU2.23-100.0- -1.14
2026-08-03AYTU2.26-100.0- -1.14
2026-08-04AYTU2.26-100.0- -1.14
2026-08-05AYTU2.30-100.0- -1.14
2026-08-06AYTU2.30-100.0- -1.14
2026-08-07AYTU2.33-100.0- -1.14
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-14AYTU0.002.223.57
2026-07-15AYTU0.002.223.57
2026-07-16AYTU0.002.223.57
2026-07-17AYTU0.002.223.57
2026-07-20AYTU0.002.243.57
2026-07-21AYTU0.002.243.57
2026-07-22AYTU0.002.243.57
2026-07-23AYTU0.002.243.57
2026-07-24AYTU0.002.243.57
2026-07-27AYTU0.002.223.55
2026-07-28AYTU0.002.223.55
2026-07-29AYTU0.002.223.55
2026-07-30AYTU0.002.223.55
2026-07-31AYTU0.002.223.55
2026-08-03AYTU0.001.813.55
2026-08-04AYTU0.001.813.60
2026-08-05AYTU0.001.813.60
2026-08-06AYTU0.001.813.60
2026-08-07AYTU0.001.813.60
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.53

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.02

Insider Transactions

Institutional Transactions

1.81

Beta

0.27

Average Sales Estimate Current Quarter

12

Average Sales Estimate Next Quarter

17

Fair Value

Quality Score

38

Growth Score

32

Sentiment Score

93

Actual DrawDown %

97.1

Max Drawdown 5-Year %

-98.7

Target Price

9.5

P/E

Forward P/E

PEG

P/S

0.45

P/B

0.72

P/Free Cash Flow

15.45

EPS

-4.58

Average EPS Est. Cur. Y​

-1.14

EPS Next Y. (Est.)

-0.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-60.17

Relative Volume

1.05

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

◆ AYTU Healthcare
$2.36
📉
Swing / Pullback
Buy the dip on strong trends
35 /100
WEAK
Trend
9/20
Pullback
8/25
Volume
4/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
63.1
Range 1M
87.7%
Sup Dist
4.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
5/25
Growth
18/30
Estimates
0/20
Inst/Vol
4/15
Options
0/10
EPS Yr
53.1%
EPS NY
92.5%
52W%
47%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +302.5% upside
Quality
6/30
Valuation
16/30
Growth
12/25
Stability
4/10
LT Trend
1/5
Upside
+302.5%
Quality
38
Click a card to see score breakdown Full Analysis →
AYTU — P/E HistoricalBiotechnology
Aytu BioPharma, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 82
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
AYTU

Latest News

—
Caricamento notizie per AYTU…
stock quote shares AYTU – Aytu BioPharma Inc. Stock Price stock today
news today AYTU – Aytu BioPharma Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AYTU – Aytu BioPharma Inc. yahoo finance google finance
stock history AYTU – Aytu BioPharma Inc. invest stock market
stock prices AYTU premarket after hours
ticker AYTU fair value insiders trading